INAB (IN8bio) FFO per Share


INAB IN8bio Inc INAB
28 GF Score
Price $1.39
View Full Analysis

What is IN8bio FFO per Share?

FFO per Share only applies to REITs.

INAB
28GF Score
IN8bio Inc INAB
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IN8bio Business Description

Address 350 5th Avenue, Suite 5330, New York, NY, USA, 10118
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.
28GF Score

Get the complete analysis for INAB

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.39
Price